NO20032765L - Terapeutisk forening av amlodipin og benazepril/benazeprilat - Google Patents

Terapeutisk forening av amlodipin og benazepril/benazeprilat

Info

Publication number
NO20032765L
NO20032765L NO20032765A NO20032765A NO20032765L NO 20032765 L NO20032765 L NO 20032765L NO 20032765 A NO20032765 A NO 20032765A NO 20032765 A NO20032765 A NO 20032765A NO 20032765 L NO20032765 L NO 20032765L
Authority
NO
Norway
Prior art keywords
amlodipine
pharmaceutically acceptable
benazepril
benazeprilat
disease
Prior art date
Application number
NO20032765A
Other languages
English (en)
Norwegian (no)
Other versions
NO20032765D0 (no
Inventor
Ann Reese Comfort
William Lionel Daley
Santo Joseph Fleres
Alan Edward Royce
Randy Lee Webb
William Shifeng Wei
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21742073&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20032765(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20032765D0 publication Critical patent/NO20032765D0/no
Publication of NO20032765L publication Critical patent/NO20032765L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO20032765A 2000-12-18 2003-06-17 Terapeutisk forening av amlodipin og benazepril/benazeprilat NO20032765L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US2000/034246 WO2002049645A1 (en) 2000-12-18 2000-12-18 Therapeutic combination of amlodipine and benazepril
PCT/US2001/048808 WO2002049646A1 (en) 2000-12-18 2001-12-17 Therapeutic combination of amlodipine and benazepril/benazeprilat

Publications (2)

Publication Number Publication Date
NO20032765D0 NO20032765D0 (no) 2003-06-17
NO20032765L true NO20032765L (no) 2003-08-14

Family

ID=21742073

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20032766A NO20032766L (no) 2000-12-18 2003-06-17 Terapeutisk forening av amlodipin og benazepril
NO20032765A NO20032765L (no) 2000-12-18 2003-06-17 Terapeutisk forening av amlodipin og benazepril/benazeprilat

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO20032766A NO20032766L (no) 2000-12-18 2003-06-17 Terapeutisk forening av amlodipin og benazepril

Country Status (27)

Country Link
EP (3) EP1365761A1 (ko)
JP (3) JP2004516266A (ko)
KR (3) KR20040007420A (ko)
CN (2) CN1461218A (ko)
AT (1) ATE338549T1 (ko)
AU (4) AU2001225816B2 (ko)
BR (2) BR0017386A (ko)
CA (2) CA2432638A1 (ko)
CY (1) CY1106275T1 (ko)
CZ (2) CZ20031678A3 (ko)
DE (1) DE60122928T2 (ko)
DK (1) DK1345607T3 (ko)
EC (1) ECSP034658A (ko)
ES (1) ES2272565T3 (ko)
HK (1) HK1059566A1 (ko)
HU (2) HUP0302455A3 (ko)
IL (4) IL156136A0 (ko)
MX (2) MXPA03005462A (ko)
NO (2) NO20032766L (ko)
NZ (1) NZ526467A (ko)
PL (2) PL362252A1 (ko)
PT (1) PT1345607E (ko)
RU (1) RU2292206C2 (ko)
SI (1) SI1345607T1 (ko)
SK (2) SK7652003A3 (ko)
WO (2) WO2002049645A1 (ko)
ZA (1) ZA200304514B (ko)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2467095A1 (en) * 2001-11-23 2003-05-30 Solvay Pharmaceuticals Gmbh Hypertonia treatment during the acute phase of a cerebrovascular accident
US20040229901A1 (en) * 2003-02-24 2004-11-18 Lauren Otsuki Method of treatment of disease using an adenosine A1 receptor antagonist
CN1859913A (zh) 2003-04-25 2006-11-08 美国诺华卡迪亚公司 改善肾功能损伤个体多尿症的方法
CA2542757A1 (en) * 2003-10-20 2005-04-28 Novartis Ag Use of organic compounds
WO2005074927A1 (en) * 2004-02-09 2005-08-18 Novartis Ag Therapeutic combination of amlodipine and benazepril/ benazeprilat for the treatment of hypertension
WO2005079772A2 (en) * 2004-02-18 2005-09-01 Sepracor Inc. Combination of (s)-amlodipine and an ace inhibitor, and methods for reducing hypertension
DE102004011512B4 (de) 2004-03-08 2022-01-13 Boehringer Ingelheim Vetmedica Gmbh Pharmazeutische Zubereitung enthaltend Pimobendan
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
EP1579862A1 (en) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
US20080268049A1 (en) * 2005-02-11 2008-10-30 Dhaliwal Mona Stable Solid Dosage Forms of Amlodipine and Benazepril
WO2006092732A2 (en) * 2005-03-04 2006-09-08 Aurobindo Pharma Ltd Stable solid dosage form of antihypertensive agent
US10130624B2 (en) 2005-03-15 2018-11-20 Lupin Limited Pharmaceutical compositions of amlodipine and benazepril
WO2007040511A1 (en) * 2005-09-28 2007-04-12 Teva Pharmaceutical Industries Ltd. Stable combinations of amlodipine besylate and benazepril hydrochloride
DK1797885T3 (da) * 2005-09-28 2008-07-14 Teva Pharma Stabil kombination af amlodipinbesylat og benazeprilhydrochlorid
US8158146B2 (en) 2005-09-28 2012-04-17 Teva Pharmaceutical Industries Ltd. Stable combinations of amlodipine besylate and benazepril hydrochloride
EP1920785A1 (en) 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Liquid preparation comprising a complex of pimobendan and cyclodextrin
SE534111C2 (sv) * 2009-09-14 2011-05-03 Scania Cv Ab Metod och system för styrning av en koppling
IT1398168B1 (it) * 2010-02-16 2013-02-14 Chiesi Farma Spa Uso di ingredienti attivi in combinazione per il trattamento delle complicanze del diabete.
WO2011161223A2 (en) 2010-06-23 2011-12-29 Krka, Tovarna Zdravil, D.D., Novo Mesto Pharmaceutical oral dosage forms comprising lercanidipine and enalapril and their pharmaceutically acceptable salts
CN102389431A (zh) * 2011-09-28 2012-03-28 济南龙华医药技术有限公司 一种含有盐酸贝尼地平和盐酸贝那普利的复方制剂及其应用
RS54475B1 (en) * 2011-12-21 2016-06-30 Novartis Tiergesundheit Ag NEW COMBINATION
US10398705B2 (en) 2012-03-15 2019-09-03 Boehringer Ingelheim Vetmedica Gmbh Pharmaceutical tablet formulation for the veterinary medical sector, method of production and use thereof
WO2014035707A1 (en) * 2012-08-25 2014-03-06 The Johns Hopkins University Gapdh cascade inhibitor compounds and methods of use and treatment of stress induced disorders including mental illness
CA2915445C (en) 2013-07-19 2024-04-23 Boehringer Ingelheim Vetmedica Gmbh Preserved etherified cyclodextrin derivatives containing liquid aqueous pharmaceutical composition
PL3106150T3 (pl) 2013-12-04 2022-01-03 Boehringer Ingelheim Vetmedica Gmbh Ulepszone kompozycje farmaceutyczne pimobendanu
EP3434284A4 (en) * 2016-03-24 2019-11-13 Daiichi Sankyo Company, Limited MEDICINE FOR THE TREATMENT OF KIDNEY DISEASE
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease
HUE064559T2 (hu) 2016-11-16 2024-03-28 H Lundbeck As MAGL inhibitor kristályos formája
UA124884C2 (uk) 2016-11-16 2021-12-08 Лундбек Ла Джолла Ресеарч Центер, Інк. Фармацевтичні склади

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6162802A (en) * 1992-03-10 2000-12-19 Papa; Joseph Synergistic combination therapy using benazepril and amlodipine for the treatment of cardiovascular disorders and compositions therefor
CA2214143A1 (en) * 1995-04-07 1996-10-10 Marc De Gasparo Combination compositions containing benazepril or benazeprilat and valsartan
EP0795327A1 (en) * 1996-03-13 1997-09-17 Pfizer Inc. Use of Amlodipine for the treatment and prophylaxis of congestive cardiac failure of non-ischaemic origin

Also Published As

Publication number Publication date
EP1345607B1 (en) 2006-09-06
WO2002049646A1 (en) 2002-06-27
CZ20031677A3 (cs) 2003-10-15
HUP0302455A3 (en) 2005-05-30
CN1481241A (zh) 2004-03-10
PL360989A1 (en) 2004-09-20
KR20040007420A (ko) 2004-01-24
MXPA03005463A (es) 2003-09-25
IL156267A0 (en) 2004-01-04
MXPA03005462A (es) 2003-09-25
HUP0302456A2 (hu) 2003-11-28
NO20032766L (no) 2003-08-14
NO20032765D0 (no) 2003-06-17
NO20032766D0 (no) 2003-06-17
IL190802A0 (en) 2008-11-03
CY1106275T1 (el) 2011-10-12
CZ20031678A3 (cs) 2003-10-15
CZ301424B6 (cs) 2010-02-24
EP1345607A1 (en) 2003-09-24
NZ526467A (en) 2005-04-29
KR20090033914A (ko) 2009-04-06
EP1365761A1 (en) 2003-12-03
SK7642003A3 (en) 2003-11-04
BR0116228A (pt) 2003-12-30
RU2292206C2 (ru) 2007-01-27
HUP0302456A3 (en) 2004-05-28
EP1674099A1 (en) 2006-06-28
CA2432638A1 (en) 2002-06-27
ATE338549T1 (de) 2006-09-15
BR0017386A (pt) 2004-01-13
ES2272565T3 (es) 2007-05-01
AU2002232620B2 (en) 2005-11-03
SI1345607T1 (sl) 2007-02-28
AU2001225816B2 (en) 2005-10-13
DE60122928T2 (de) 2007-09-06
JP2010043111A (ja) 2010-02-25
AU2002232620B9 (en) 2005-11-24
PT1345607E (pt) 2007-01-31
CN1461218A (zh) 2003-12-10
WO2002049645A1 (en) 2002-06-27
PL362252A1 (en) 2004-10-18
DK1345607T3 (da) 2006-12-27
IL190801A0 (en) 2008-11-03
RU2003121019A (ru) 2005-01-20
JP2004516266A (ja) 2004-06-03
AU2581601A (en) 2002-07-01
JP2004519440A (ja) 2004-07-02
HK1059566A1 (en) 2004-07-09
DE60122928D1 (de) 2006-10-19
HUP0302455A2 (hu) 2003-11-28
AU3262002A (en) 2002-07-01
ZA200304514B (en) 2004-05-10
SK7652003A3 (en) 2003-12-02
IL156136A0 (en) 2003-12-23
ECSP034658A (es) 2003-07-25
CA2432282A1 (en) 2002-06-27
KR20030061840A (ko) 2003-07-22

Similar Documents

Publication Publication Date Title
NO20032765D0 (no) Terapeutisk forening av amlodipin og benazepril/benazeprilat
RU2243768C2 (ru) Гипотензивная комбинация валсартана и блокатора кальциевых каналов
WO2005070462A2 (en) Compositions comprising (s)-amlodipine and an angiotensin receptor blocker and methods of their use
ATE370732T1 (de) Pharmazeutische zusammensetzung enthaltend valsartan und nep-inhibitoren
RU93055870A (ru) Производные бифенила, способ их получения и фармацевтическая композиция для лечения гипертонии и сердечных заболеваний
EA022612B1 (ru) Комбинация и композиция селективного и специфического ингибитора тока синусового узла iи агента, который ингибирует ангиотензинпревращающий фермент, и их применение для лечения сердечной недостаточности
WO2003041725A3 (de) REGULATION DER cGMP-SPEZIFISCHEN PHOSPHODIESTERASE 9A
KR20090047424A (ko) 굴심방 결절 Ｉｆ 전류 억제제와 앤지오텐신 전환 효소 억제제의 회합체, 및 이를 함유한 약제 조성물
KR100907584B1 (ko) 굴심방 결절 Ｉｆ 전류 억제제 및 칼슘채널억제제의 회합체 및 이를 함유하는 약제 조성물
SG153644A1 (en) Therapeutic combination of amlodipine and benazepril
RU2005119970A (ru) Оптически активное производное дигидропиридина
DK0554107T3 (da) Substituerede triazoler som angiotensin II inhibitorer
RU2002113666A (ru) Применение 2-имидазолилзамещенных карбинолов для получения лекарственного средства для лечения или профилактики заболеваний, обусловленных ишемическими состояниями
Landau et al. Calcium antagonists for the treatment of congestive heart failure
RU2003121016A (ru) Терапевтическая комбинация амлодипина и беназеприла
WO2003007964A1 (fr) Remede ou agent preventif de cardiopathie ou d'anevrysme contenant un compose d'inhibition de la chymase
US9393228B2 (en) Combination of a slow sodium current blocker and a sinus If current inhibitor, and the pharmaceutical compositions containing said combination

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application